Related references
Note: Only part of the references are listed.Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
David M. Yurek et al.
MOLECULAR THERAPY (2009)
AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons
J. D. Elsworth et al.
EXPERIMENTAL NEUROLOGY (2008)
Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA
Xuguang Chen et al.
MOLECULAR THERAPY (2008)
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
Ivar Mendez et al.
NATURE MEDICINE (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: The role of immunological synapses in understanding the cell biology of neuroimmune interactions
Pedro R. Lowenstein et al.
CURRENT GENE THERAPY (2007)
Efficacy of nonviral gene transfer in the canine brain
Seunguk Oh et al.
JOURNAL OF NEUROSURGERY (2007)
Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway
Samuel K. Lai et al.
BIOMATERIALS (2007)
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
Rafal Farjo et al.
PLOS ONE (2006)
Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles
T. L. Fink et al.
GENE THERAPY (2006)
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space
RG Thorne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells
S Nimesh et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Organically modified silica nanoparticles:: A nonviral vector for in vivo gene delivery and expression in the brain
DJ Bharali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor
YH Ahn et al.
BRAIN RESEARCH BULLETIN (2005)
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
MW Konstan et al.
HUMAN GENE THERAPY (2004)
Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor
B Georgievska et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Nanoparticles of compacted DNA transfect postmitotic cells
G Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo
AG Ziady et al.
MOLECULAR THERAPY (2003)
Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung
AG Ziady et al.
MOLECULAR THERAPY (2003)
Cellular replacement therapy for Parkinson's disease - Where we are today?
DE Redmond
NEUROSCIENTIST (2002)
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter
DR Gill et al.
GENE THERAPY (2001)
Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval
CE Sortwell et al.
EXPERIMENTAL NEUROLOGY (2001)
Cell therapy and transplantation in Parkinson's disease
O Lindvall et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion
DM Yurek et al.
BRAIN RESEARCH (2001)
Time course of apoptotic cell death within mesencephalic cell suspension grafts: Implications for improving grafted dopamine neuron survival
CE Sortwell et al.
EXPERIMENTAL NEUROLOGY (2000)
Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach
C Schmitz et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)
Improving the survival of grafted dopaminergic neurons:: A review over current approaches
P Brundin et al.
CELL TRANSPLANTATION (2000)
Share Paper
